Denmark · Delayed Price · Currency is DKK CPH:SMSMED Statistics
Total Valuation
CPH:SMSMED has a market cap or net worth of DKK 74.52 million. The enterprise value is 147.05 million.
| Market Cap | 74.52M |
| Enterprise Value | 147.05M |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CPH:SMSMED has 27.81 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 27.81M |
| Shares Outstanding | 27.81M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 53.60 |
| PS Ratio | 0.35 |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.68 |
| EV / EBITDA | 49.55 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.46 |
| Quick Ratio | 0.27 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 24.93 |
| Debt / FCF | -3.13 |
| Interest Coverage | -2.19 |
Financial Efficiency
Return on equity (ROE) is -9.97% and return on invested capital (ROIC) is -4.69%.
| Return on Equity (ROE) | -9.97% |
| Return on Assets (ROA) | -2.25% |
| Return on Invested Capital (ROIC) | -4.69% |
| Return on Capital Employed (ROCE) | -6.32% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | 6.94M |
| Profits Per Employee | -246,484 |
| Employee Count | 31 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 1.97 |
Taxes
| Income Tax | -2.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.49% in the last 52 weeks. The beta is 0.24, so CPH:SMSMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -42.49% |
| 50-Day Moving Average | 2.96 |
| 200-Day Moving Average | 3.70 |
| Relative Strength Index (RSI) | 40.29 |
| Average Volume (20 Days) | 29,259 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CPH:SMSMED had revenue of DKK 214.99 million and -7.64 million in losses. Loss per share was -0.28.
| Revenue | 214.99M |
| Gross Profit | 27.32M |
| Operating Income | -6.82M |
| Pretax Income | -9.94M |
| Net Income | -7.64M |
| EBITDA | 2.97M |
| EBIT | -6.82M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 1.45 million in cash and 73.98 million in debt, with a net cash position of -72.53 million or -2.61 per share.
| Cash & Cash Equivalents | 1.45M |
| Total Debt | 73.98M |
| Net Cash | -72.53M |
| Net Cash Per Share | -2.61 |
| Equity (Book Value) | 72.85M |
| Book Value Per Share | 2.62 |
| Working Capital | 40.62M |
Cash Flow
In the last 12 months, operating cash flow was -4.69 million and capital expenditures -18.93 million, giving a free cash flow of -23.62 million.
| Operating Cash Flow | -4.69M |
| Capital Expenditures | -18.93M |
| Depreciation & Amortization | 9.79M |
| Net Borrowing | 24.51M |
| Free Cash Flow | -23.62M |
| FCF Per Share | -0.85 |
Margins
Gross margin is 12.71%, with operating and profit margins of -3.17% and -3.55%.
| Gross Margin | 12.71% |
| Operating Margin | -3.17% |
| Pretax Margin | -4.62% |
| Profit Margin | -3.55% |
| EBITDA Margin | 1.38% |
| EBIT Margin | -3.17% |
| FCF Margin | n/a |
Dividends & Yields
CPH:SMSMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | -0.61% |
| Earnings Yield | -10.25% |
| FCF Yield | -31.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPH:SMSMED has an Altman Z-Score of 2.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.3 |
| Piotroski F-Score | 1 |